Ability Pharma
-
DATABASE (48)
-
ARTICLES (111)
Established by Chinese Academy of Sciences Holdings Co., Ltd., and several other conglomerates in 2011, Cash Capital invests mainly in high-tech startups in the IoT, intelligent manufacturing, mobile internet, big data, artificial intelligence, fintech, healthcare, medical equipment and pharmaceutical sectors. The firm manages assets of more than RMB 10 billion and has invested in nearly 100 companies.
Established by Chinese Academy of Sciences Holdings Co., Ltd., and several other conglomerates in 2011, Cash Capital invests mainly in high-tech startups in the IoT, intelligent manufacturing, mobile internet, big data, artificial intelligence, fintech, healthcare, medical equipment and pharmaceutical sectors. The firm manages assets of more than RMB 10 billion and has invested in nearly 100 companies.
Yueyin Venture Capital was founded in 2015 in Beijing. It manages total assets worth US$300m, with investments in 22 companies. The VC focuses mainly in the healthcare, pharmaceutical and biotech sectors.
Yueyin Venture Capital was founded in 2015 in Beijing. It manages total assets worth US$300m, with investments in 22 companies. The VC focuses mainly in the healthcare, pharmaceutical and biotech sectors.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. It has invested in 50 companies and manages RMB2bn worth of total assets. Bioventure invests mostly in the life sciences and bio-pharmaceutical industries, seeking early-stage startups with high growth potential. Bioventure provides post-investment support and services including funding, business operations and management.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. It has invested in 50 companies and manages RMB2bn worth of total assets. Bioventure invests mostly in the life sciences and bio-pharmaceutical industries, seeking early-stage startups with high growth potential. Bioventure provides post-investment support and services including funding, business operations and management.
Renhe Group was founded in Jiangxi Province by Yang Wenlong in 2001. The group, including its flagship listed Renhe Pharmacy, earned total sales revenue of RMB 11.23bn in 2018 with a year-on-year profit growth of 25%. The group comprises 20 subsidiaries dealing in cosmetics, household chemicals, pharmaceutical, medical supplies and equipment.
Renhe Group was founded in Jiangxi Province by Yang Wenlong in 2001. The group, including its flagship listed Renhe Pharmacy, earned total sales revenue of RMB 11.23bn in 2018 with a year-on-year profit growth of 25%. The group comprises 20 subsidiaries dealing in cosmetics, household chemicals, pharmaceutical, medical supplies and equipment.
Founded in 2014, Prosperico Ventures targets the healthcare sector. The VC has invested in nearly 30 startups working on medical devices, pharmaceutical R&D, provision of medical services and precision medicine.
Founded in 2014, Prosperico Ventures targets the healthcare sector. The VC has invested in nearly 30 startups working on medical devices, pharmaceutical R&D, provision of medical services and precision medicine.
Formerly known as Guangdong Technology Venture Capital Group, Technology Financial Group is a state-owned firm based in Guangzhou. It has a subsidiary in Guangdong province and has set up nine offices in other provinces across China. Technology Financial Group began investing in companies when it was founded in 1992, and it has assets under management of RMB 50bn. With a focus on VC investment, it also provides financial services such as asset management.The firm invests mainly in the high-end equipment manufacturing; new-generation information technology; new material; art, entertainment and media; consumption; biotech and pharmacy; energy and environmental protection; and automotive sectors.
Formerly known as Guangdong Technology Venture Capital Group, Technology Financial Group is a state-owned firm based in Guangzhou. It has a subsidiary in Guangdong province and has set up nine offices in other provinces across China. Technology Financial Group began investing in companies when it was founded in 1992, and it has assets under management of RMB 50bn. With a focus on VC investment, it also provides financial services such as asset management.The firm invests mainly in the high-end equipment manufacturing; new-generation information technology; new material; art, entertainment and media; consumption; biotech and pharmacy; energy and environmental protection; and automotive sectors.
Carlos Gallardo is an industrial engineer with an MBA from Stanford University. He spent most of his career at the pharmaceutical company Almirall and was promoted through the ranks rapidly holding multiple C-level roles. He became the MD for UK and Ireland for over five years and joined Almirall’s board of directors in 2014.In 2015, he founded CG Health Ventures, a VC firm investing in early-stage digital health companies worldwide. He’s also an active angel investor and advisor for startups developing frontier technologies in the healthcare sector.
Carlos Gallardo is an industrial engineer with an MBA from Stanford University. He spent most of his career at the pharmaceutical company Almirall and was promoted through the ranks rapidly holding multiple C-level roles. He became the MD for UK and Ireland for over five years and joined Almirall’s board of directors in 2014.In 2015, he founded CG Health Ventures, a VC firm investing in early-stage digital health companies worldwide. He’s also an active angel investor and advisor for startups developing frontier technologies in the healthcare sector.
Baiyang Capital was founded in 2014 by BAHEAL Pharmaceutical Holdings Limited and several senior professionals in the pharmaceutical and healthcare fields. The investment management company operates multiple funds, targeting pharmaceutical and healthcare businesses.
Baiyang Capital was founded in 2014 by BAHEAL Pharmaceutical Holdings Limited and several senior professionals in the pharmaceutical and healthcare fields. The investment management company operates multiple funds, targeting pharmaceutical and healthcare businesses.
Zhongguancun Longmen Investment
Investing in hi-tech IT, advanced manufacturing and biotechnology sectors – key pillars of China’s innovation-focused economy since 2017 – the Beijing government-backed Beijing Zhongguancun Longmen Investment manages about RMB 10bn via its first fund of the same name. The firm is founded and led by Xu Jinghong, former Chairman of Tsinghua Holdings, the investment and tech/R&D transfer arm of China’s most prestigious science and research university, whose R&D capacity was ranked in the third place of China’s top 500 enterprises in 2018. The LPs of the fund include social security funds, Beijing’s municipal government and the Haidian District government. Its portfolio enterprises are generally ranked in the top three of their respective industries. Among them, Qi An Xin Technology, which is listed in Shanghai and one of China’s biggest cybersecurity companies; Joy Wing Mao, one of China’s major fruits supply chain companies. In October of 2020, it invested RMB 100m into Beijing Immunochina Pharmaceutical, which develops innovative gene and cell therapies for curing malignant tumors. Longmen also provides mentoring and other expertise and support to its investee startups, especially those that plan to seek public listing.
Investing in hi-tech IT, advanced manufacturing and biotechnology sectors – key pillars of China’s innovation-focused economy since 2017 – the Beijing government-backed Beijing Zhongguancun Longmen Investment manages about RMB 10bn via its first fund of the same name. The firm is founded and led by Xu Jinghong, former Chairman of Tsinghua Holdings, the investment and tech/R&D transfer arm of China’s most prestigious science and research university, whose R&D capacity was ranked in the third place of China’s top 500 enterprises in 2018. The LPs of the fund include social security funds, Beijing’s municipal government and the Haidian District government. Its portfolio enterprises are generally ranked in the top three of their respective industries. Among them, Qi An Xin Technology, which is listed in Shanghai and one of China’s biggest cybersecurity companies; Joy Wing Mao, one of China’s major fruits supply chain companies. In October of 2020, it invested RMB 100m into Beijing Immunochina Pharmaceutical, which develops innovative gene and cell therapies for curing malignant tumors. Longmen also provides mentoring and other expertise and support to its investee startups, especially those that plan to seek public listing.
LeapFrog Investments is an impact-focused investor, managing over $1.6bn in assets mainly investing in Africa and Asia. Its “profit with purpose” has led to investments in startups that provide healthcare, financial services and insurance for low-income consumers. Since it was founded in 2007, LeapFrog has attracted funds from Prudential, AXA, Swiss Re and Omidyar Network, becoming the first impact investor in the world to reach the $1bn milestone. It’s headquartered in South Africa and Singapore.LeapFrog is best known for its investments in the insurance sector. One of the most prominent companies in its portfolio is BIMA, the mobile-based insurance provider that has provided coverage in Ghana, Bangladesh, Cambodia and many other countries. In 2020, LeapFrog invested in Indonesian startup PasarPolis, which is a broker for a wide range of microinsurance products. In the healthcare and biotechnology sectors, LeapFrog has funded Indian genetic diagnostics company MedGenome, as well as Goodlife Pharmacy, a Kenyan company providing access to affordable medicine in the East African country.
LeapFrog Investments is an impact-focused investor, managing over $1.6bn in assets mainly investing in Africa and Asia. Its “profit with purpose” has led to investments in startups that provide healthcare, financial services and insurance for low-income consumers. Since it was founded in 2007, LeapFrog has attracted funds from Prudential, AXA, Swiss Re and Omidyar Network, becoming the first impact investor in the world to reach the $1bn milestone. It’s headquartered in South Africa and Singapore.LeapFrog is best known for its investments in the insurance sector. One of the most prominent companies in its portfolio is BIMA, the mobile-based insurance provider that has provided coverage in Ghana, Bangladesh, Cambodia and many other countries. In 2020, LeapFrog invested in Indonesian startup PasarPolis, which is a broker for a wide range of microinsurance products. In the healthcare and biotechnology sectors, LeapFrog has funded Indian genetic diagnostics company MedGenome, as well as Goodlife Pharmacy, a Kenyan company providing access to affordable medicine in the East African country.
Beijing Zhongguancun Development Qihang Industrial Investment Fund
Beijing Zhongguancun Development Qihang Industrial Investment Fund was launched by Zhongguancun Development Group, a hi-tech commercialization platform backed by the municipal government of Beijing. It focuses on biotechnology, pharmaceuticals, next-generation information technology, new energy, new materials and intelligent manufacturing.
Beijing Zhongguancun Development Qihang Industrial Investment Fund was launched by Zhongguancun Development Group, a hi-tech commercialization platform backed by the municipal government of Beijing. It focuses on biotechnology, pharmaceuticals, next-generation information technology, new energy, new materials and intelligent manufacturing.
Founded in 2009, Septwolves Venture Capital is a subsidiary of Septwolves Holding Group Co Ltd. The VC firm currently manages assets worth RMB 1bn.Focusing on investment opportunities in the communications and other traditional industries like logistics, Septwolves also invests in diverse sectors including mobile internet, energy, food, pharmaceutical, textile and software.
Founded in 2009, Septwolves Venture Capital is a subsidiary of Septwolves Holding Group Co Ltd. The VC firm currently manages assets worth RMB 1bn.Focusing on investment opportunities in the communications and other traditional industries like logistics, Septwolves also invests in diverse sectors including mobile internet, energy, food, pharmaceutical, textile and software.
Founded in 2018, Trinity Innovation Fund is a fund management firm that mainly invests in pharmaceutical innovations. TIF currently manages two PE funds and its limited partners include renowned pharmaceuticals and institutional investors. It also has offices managing funds overseas, for example, Trinity Innovation Bioventure Singapore Pte Ltd.
Founded in 2018, Trinity Innovation Fund is a fund management firm that mainly invests in pharmaceutical innovations. TIF currently manages two PE funds and its limited partners include renowned pharmaceuticals and institutional investors. It also has offices managing funds overseas, for example, Trinity Innovation Bioventure Singapore Pte Ltd.
Founded by Hillhouse Capital in February 2020, GL Ventures mainly invests in early-stage startups from diverse sectors like pharmaceutical, SaaS, internet-based consumption/technology and emerging consumer goods/services.The RMB/USD dual currency VC-arm of Hillhouse currently manages total funds worth RMB 10bn from limited partners including university endowments, sovereign wealth funds, pension funds, FOF and family offices. The VC has made nearly 200 investments in its first year of operations.
Founded by Hillhouse Capital in February 2020, GL Ventures mainly invests in early-stage startups from diverse sectors like pharmaceutical, SaaS, internet-based consumption/technology and emerging consumer goods/services.The RMB/USD dual currency VC-arm of Hillhouse currently manages total funds worth RMB 10bn from limited partners including university endowments, sovereign wealth funds, pension funds, FOF and family offices. The VC has made nearly 200 investments in its first year of operations.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Daniel Oliver: Building a "Facebook" for investments in biotech startups
The biologist and crowdfunding expert has pioneered the growth of Spanish biotech startups, providing access to early-stage investments, with support from scientific experts worldwide
South Summit 2021: Martin Varavsky, Leandro Sigman on post-Covid healthcare trends
Serial entrepreneur Martin Varavsky and Insud Pharma Chairman Leandro Sigman share their thoughts and projections on the future of health tech
TurtleTree Labs: Creating sustainable mammalian milk alternatives from stem cells
Founder’s search for high-quality dairy milk led to the creation in a lab of naturally occurring ingredients found in human milk for supply to dairy milk and infant formula businesses
Gorry Holdings: Promoting staff wellness in Indonesia
The healthtech startup wants companies to understand how healthy employees can translate into good business
Animal AgTech Innovation Summit 2021: Experts discuss post-pandemic priorities
The pandemic not only put digital tech in everyone’s hands, it also forced thinking about collecting meaningful data and moving it on-demand to both producers and decision makers
How Sequoia Capital China is helping its portfolio startups get through the Covid-19 crisis
The renowned investor is also making big bets on the opportunities that lie head
Meatable joins Royal DSM to create growth media specific for cell-based meat tech
The R&D between the biotech startup and fellow Dutch nutrition conglomerate could help scale and drive the commercial viability of lab-grown meat
Backed by pharmas, doctors, medtech startup DyCare is expanding fast across Europe
Its remote musculoskeletal rehabilitation and monitoring system sets to improve rehabilitation outcomes in an overtaxed sector
iLoF: Accelerating access to personalized medicine, from a drop of blood
Backed by Microsoft’s venture fund M12, Mayfield and Melinda Gates’s Pivotal Ventures, iLoF focuses on painless screening to facilitate disease detection, forecasting and drug development, from Alzheimer’s to Covid-19
Biomilq: Creating cell-based mothers’ milk in a lab
With the aim of helping women struggling to breastfeed, Bill Gates-backed Biomilq is disrupting the $45bn baby formula industry developing lab-grown breast milk from mammary epithelial cells
IOMED: Delivering structured, extractable patient big data and helping Spain's Covid-19 response
The medtech cuts the time spent on finding candidates for medical research by 90% and last month secured €2m in seed funding to take its software overseas
Singapore, the place to start and grow a cellular agriculture startup
A country that imports over 90% of its food supply, Singapore has turned to foodtech, including cellular agriculture, to safeguard food security, supported by proactive regulators
Sound Particles: the CGI for sound effects taking Hollywood by storm
This revolutionary 3D audio software has propelled Portuguese founder Nuno Fonseca from teaching music to credits in Star Wars, Game of Thrones and Frozen II.
New Food Invest: Challenges of growing an alt-protein startup
Founders of three alt-protein startups in the US share what motivated them to start, their personal experiences growing the businesses, getting funding and finding strategic partners
This app lets you show off your cat on social media
Is Meowcard the next big thing or a flash in the pan?
Sorry, we couldn’t find any matches for “Ability Pharma”.
